SCHEMBL27698210

SCHEMBL27698210

NC(=O)c1cc(-c2cccs2)cc2cn[nH]c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 2/20 0.52
▸ BTK Q06187 2/20 0.52
▸ AURKA O14965 2/20 0.52
▸ RET P07949 2/20 0.52
▸ FGFR1 P11362 2/20 0.52
▸ LTK P29376 2/20 0.52
▸ KDR P35968 2/20 0.52
▸ MAP2K2 P36507 2/20 0.52
▸ FLT3 P36888 2/20 0.52
▸ CSNK1A1 P48729 2/20 0.52
▸ CDK5 Q00535 2/20 0.52
▸ MAP2K1 Q02750 2/20 0.52
▸ PRKAA1 Q13131 2/20 0.52
▸ CAMK1D Q8IU85 2/20 0.52
▸ CLK4 Q9HAZ1 2/20 0.52
▸ DYRK1B Q9Y463 2/20 0.52
▸ ROCK1 Q13464 2/20 0.52
▸ PLK4 O00444 1/20 0.52
▸ DAPK3 O43293 1/20 0.52
▸ MAP4K4 O95819 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27698209 0.80 IKBKB (0.61) CHEK1BTKAURKARETFGFR1
SCHEMBL27709861 0.79 IKBKB (0.64) CHEK1BTKCDC7CHEK2PTPN1
SCHEMBL27698212 0.78 CHEK1 (0.50) CHEK1BTKAURKARETFGFR1
SCHEMBL1421939 0.71 BTK (0.58) CHEK1BTKAURKARETFGFR1
SCHEMBL13606474 0.71 CDK5 (0.48) CHEK1BTKCDK5CLK4ROCK1
SCHEMBL23185496 0.70 BTK (0.57) CHEK1BTKAURKARETFGFR1
SCHEMBL16258828 0.70 BTK (0.57) CHEK1BTKAURKARETFGFR1
SCHEMBL20487617 0.70 BTK (0.57) CHEK1BTKAURKARETFGFR1
SCHEMBL29232675 0.70 BTK (0.57) CHEK1BTKAURKARETFGFR1
SCHEMBL28494095 0.70 ADORA2A (0.50) CHEK1BTKAURKARETFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101005836-A Novel indazole carboxamides and their use SMITHKLINE BEECHAM CORP (US) 2007-07-25 — — CN disclosed
Send feedback